诚达药业一股东拟清仓式减持

Group 1 - The core point of the article is that Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership), a shareholder holding 11,006,900 shares (7.27% of the total share capital after excluding repurchased shares) of Chengda Pharmaceutical (301201.SZ), plans to reduce its holdings within a specified timeframe [1] Group 2 - The planned reduction of shares will occur through centralized bidding or block trading methods [1] - The reduction period is set from September 29, 2025, to December 28, 2025 [1] - The maximum number of shares to be reduced is also 11,006,900, maintaining the same percentage of 7.27% of the total share capital after excluding repurchased shares [1]